There were also significant differences in HP and PDIA3 levels between colorectal cancer patients at an early stage and those at the progressive stage, indicating that HP and PDIA3 expressions were high in malignant tumors and would continuously increase alongside disease progression. Here, HP is linked to colorectal cancer.